The shifting landscape of pancreatic cancer research funding.

• DOI: 10.1200/jco.2014.32.15_suppl.e17545
• Publication Date: 2019-01-03T22:34:11Z
• Authors: Carlyn Rose Co Tan; Rhonda Aizenberg; Lynne Davies; Lynn Matrisian; Xiao Zhang; Richard Tuli; Andrew Eugene Hen...
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

e17545 Background: Although pancreatic cancer is the fourth most common cause of death, it only receives approximately 2% federal dollars distributed by NCI. Recognizing need for research support, patient advocacy groups and private institutions are playing a growing role in providing funding to supplement government funds. Methods: The International Cancer Research Partnership (ICRP) an alliance governmental charitable organizations regional, national international grants awards which provides key information about ongoing historical funding. We interrogated publicly available ICRP database corresponding scientific outline (CSO) codes review number (> 80% relevance) awarded from 2008 2012. compared total non-U.S. Results: that include decreased 44% (909 vs 507 awards) Among focused on percentage non-government entities US increased 17% 22% during same time period. Analy.sis CSO categories over this 5 year period suggests community-based predominantly Biology (CSO1), Early diagnosis, detection, prognosis (CSO4), Treatment (CSO5). It also demonstrates increasing emphasis Etiology (CSO2) Prevention (CSO3) activity Conclusions: U.S. continues provide large portion (75 80%) research. However, data 2012 while increased. data: cancer, - Non-U.S. governmet (# CY2008 CY2010 CY2012 1 biology 48% 2 etiology 3% 5% 9% 3 prevention 1% 6% 4 early 12% treatment 32% 27% 24% 6 control, survivorship, outcomes 4% 7 Scientific Model Systems